People channel feed – Endpoints News

People channel feed

Esperion's CMO hits the exit; Pfizer appoints Nvidia alum as AI chief

10 months ago

Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company

10 months ago

Updated: Lykos cutting most of staff less than a week after FDA rejection

10 months ago

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

11 months ago

Lilly opens huge new Boston research center, with a focus on genetic medicines

11 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

11 months ago

Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO

11 months ago

Infectious disease biotech undergoes makeover after lung disease trial underwhelms

11 months ago

Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

11 months ago

Entero Therapeutics turns the lights off as creditors come calling

11 months ago

Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering

11 months ago

Bicycle Therapeutics focuses pipeline and streamlines leadership team

11 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

11 months ago

Exclusive: Biotech investor Sofinnova hires former Biogen medical chief

11 months ago

Bristol Myers to cut more jobs at headquarters as part of announced restructure

11 months ago

Q&A: Genentech's new CEO on AI, IRA and radiopharma

11 months ago

Florida CNS gene therapy biotech shuts down

11 months ago

PARP biotech backed by more than five pharmas closes after nine years

11 months ago

Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down

11 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

11 months ago

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

11 months ago

Updated: Jim Wilson to step down from gene therapy post at UPenn, will form two new companies

11 months ago

After norovirus vaccine's trial failure, HilleVax lays off 40% of staff

11 months ago

FibroGen to shrink US workforce by 75% following more late-stage fails

11 months ago

First page Previous page 8 9 101112 13 14 Next page Last page